Vivozon Pharmaceutical Co., Ltd.

KOSDAQ:A082800 Stock Report

Market Cap: ₩156.5b

Vivozon Pharmaceutical Balance Sheet Health

Financial Health criteria checks 4/6

Vivozon Pharmaceutical has a total shareholder equity of ₩103.1B and total debt of ₩37.6B, which brings its debt-to-equity ratio to 36.4%. Its total assets and total liabilities are ₩169.9B and ₩66.8B respectively. Vivozon Pharmaceutical's EBIT is ₩5.1B making its interest coverage ratio 2.2. It has cash and short-term investments of ₩10.4B.

Key information

36.4%

Debt to equity ratio

₩37.57b

Debt

Interest coverage ratio2.2x
Cash₩10.45b
Equity₩103.11b
Total liabilities₩66.78b
Total assets₩169.89b

Recent financial health updates

Recent updates

Some Shareholders Feeling Restless Over Vivozon Pharmaceutical Co., Ltd.'s (KOSDAQ:082800) P/S Ratio

Jun 04
Some Shareholders Feeling Restless Over Vivozon Pharmaceutical Co., Ltd.'s (KOSDAQ:082800) P/S Ratio

We Think Vivozon Pharmaceutical (KOSDAQ:082800) Has A Fair Chunk Of Debt

Mar 23
We Think Vivozon Pharmaceutical (KOSDAQ:082800) Has A Fair Chunk Of Debt

Is Vivozon Healthcare (KOSDAQ:082800) A Risky Investment?

May 06
Is Vivozon Healthcare (KOSDAQ:082800) A Risky Investment?

Estimating The Intrinsic Value Of Vivozon Healthcare, Inc. (KOSDAQ:082800)

Feb 18
Estimating The Intrinsic Value Of Vivozon Healthcare, Inc. (KOSDAQ:082800)

Did You Miss Vivozon Healthcare's (KOSDAQ:082800) Impressive 116% Share Price Gain?

Dec 04
Did You Miss Vivozon Healthcare's (KOSDAQ:082800) Impressive 116% Share Price Gain?

Financial Position Analysis

Short Term Liabilities: A082800's short term assets (₩39.3B) do not cover its short term liabilities (₩62.0B).

Long Term Liabilities: A082800's short term assets (₩39.3B) exceed its long term liabilities (₩4.8B).


Debt to Equity History and Analysis

Debt Level: A082800's net debt to equity ratio (26.3%) is considered satisfactory.

Reducing Debt: A082800's debt to equity ratio has increased from 34.7% to 36.4% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: A082800 has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: A082800 has sufficient cash runway for 1.1 years if free cash flow continues to grow at historical rates of 9.3% each year.


Discover healthy companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.